




	
	  if (document.domain != 'www.netvibes.com') {	  
		  document.write(
'\n\t\n<style>\ndiv.vbp-widget * {\n    margin: 0;\n    padding: 0;\n    line-height:normal;\n    border:none;\n    text-transform:none;\n    \n}\n\ndiv.vbp-widget {\n    border: 1px solid #CCC;\n    color: #222;\n    margin: 0 auto;\n    background: #EEE;\n    font-family: \'Helvetica Neue\', Arial, sans-serif;\n    font-size: 12px;\n}\n\ndiv.vbp-widget a,\ndiv.vbp-widget a:link,\ndiv.vbp-widget a:visited {\n    text-decoration: none;\n    color: #35D;\n}\ndiv.vbp-widget a:hover {\n    text-decoration: underline;\n} \n\n/**** header ****/\n\ndiv.vbp-widget .vbp-header {\n    background: #DDD;\n    height: 44px;\n    border-bottom: 1px solid #BBB;\n    background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x top left;\n    padding: 5px 15px;\n}\n\ndiv.vbp-widget p.vbp-company {\n    padding-top: 3px;\n    margin-right: 140px;\n    float: left;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-company a {\n}\ndiv.vbp-widget .vbp-company a * {\n    display: block;\n}\n\ndiv.vbp-widget .vbp-company a strong {\n    font-size: 18px;\n    color: #333;\n    text-shadow: 0 2px 1px #FFF;\n    font-weight: bold;\n}\ndiv.vbp-widget .vbp-company a em {\n    font-style: normal;\n    font-size: 11px;\n    color: #346;\n}\n\ndiv.vbp-widget a img {\n    border: none;\n}\n\ndiv.vbp-widget .vbp-header img, div.vbp-widget .vbp-header a img {\n    float: right;\n    border: 1px solid #CCC;\n}\n\ndiv.vbp-widget p.vbp-utility {\n    width: 120px;\n    float: right;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-utility a {\n    display: block;\n    padding: 2px 5px;\n    font-size: 11px;\n    -moz-border-radius: 3px;\n\t-webkit-border-radius: 3px;\n    margin-right: 5px;\n    margin-bottom: 3px;\n}\ndiv.vbp-widget .vbp-utility a:link,\ndiv.vbp-widget .vbp-utility a:visited {\n    background: rgba(0,0,0,.08);\n    color: #111;\n    text-shadow: 0 1px 1px hsla(0,0%,100%,1);\n}\ndiv.vbp-widget .vbp-utility a:hover {\n    background: #459;\n    color: #FFF;\n    text-decoration: none;\n    text-shadow: none;\n}\n\n/**** content ****/\n\ndiv.vbp-widget div.vbp-content {\n    padding: 8px 0;\nbackground-color:#fff;\n}\n\ndiv.vbp-widget .vbp-col {\n    width: 46%;\n    float: left;\n    margin: 0 2%;\n}\n\ndiv.vbp-widget div.vbp-content p,\ndiv.vbp-widget div.vbp-content h5 {\n    padding-left: 5px;\n}\n\ndiv.vbp-widget p {\n\tmargin-top: 0px;\n  font-size: 12px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-categogy {\n    clear: both;\n    margin-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content h5 {\n    font-size: 12.5px;\n    background: #F4F4F4;\n    color: #444;\n    padding-top: 2px;\n    padding-bottom: 2px;\n    background: #F4F4F4 url(http://venturebeatprofiles.com/images/widget_heading_bg.gif) repeat-x left bottom;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p {\n    border-top: 1px dotted #E4E4E4;\n    padding-top: 4px;\n    padding-bottom: 4px;\n    margin:0;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p strong {\n    font-size: 11px;\n    text-transform: uppercase;\n    color: #88A;\n}\n\ndiv.vbp-widget div.vbp-content a:link,\ndiv.vbp-widget div.vbp-content a:visited {\n    color: #35D;\n}\ndiv.vbp-widget div.vbp-content a:hover {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-description, div.vbp-widget p.vbp-description-long, div.vbp-widget p.vbp-description-short {\n    padding-top: 2px;\n    padding-bottom: 8px;\n}\n\ndiv.vbp-widget .vbp-description img, div.vbp-widget .vbp-description-long img div.vbp-widget .vbp-description-short img {\n    float: left;\n    border: 1px solid #CCC;\n    margin: 0 8px 8px 0;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news {\n    margin-bottom: 0;\n    padding-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p {\n    padding-top: 4px;\n    padding-bottom: 4px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a {\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a * { display: block; }\n\ndiv.vbp-widget div.vbp-content .vbp-news p a em {\n    font-size: 10px;\n    text-transform: uppercase;\n    font-style: normal;   \n    color: #666;\n    letter-spacing: 0.08em;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a strong {\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover {\n    text-decoration: none;\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover * {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-footer {\n    border-top: 1px solid #CCC;\n    padding: 5px 10px;\n    color: #888;\n    height: 15px;\n    font-size: 11px;\n    text-shadow: 0 1px 1px #FFF;\n}\n\ndiv.vbp-widget .vbp-footer a {\n}\n\ndiv.vbp-widget .vbp-header,\ndiv.vbp-widget .vbp-footer {\n  background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x left top;\n}\n\n/**** clearfix ****/\n\n.clearfix:after {\n  content: \'\';\n  display: block;\n  height: 0;\n  clear: both;\n  visibility: hidden;\n }\n\n.tradevibes_hidden, .vbp-hide {\n\tdisplay:none !important;\n}\n</style>\n\n\n\n\n<script type="text/javascript">\n\tvar tv_long_cls = \'vbp-description-long\';\n\tvar tv_short_cls = \'vbp-description-short\';\n\tvar tv_hid = \'vbp-hide tradevibes_hidden\';\n\tfunction tradevibes_toggle_description(e) {\n\t\tvar targ;\n\t\tif (!e) var e = window.event;\n\t\tif (e.target) targ = e.target;\n\t\telse if (e.srcElement) targ = e.srcElement;\n\t\tif (targ.nodeType == 3) // defeat Safari bug\n\t\t\ttarg = targ.parentNode;\n\n\t\tvar parent = targ.parentNode;\n\t\tif (parent.className.indexOf(tv_short_cls) != -1) {\n\t\t\t// short description is visible\n\t\t\tparent.className = tv_hid + \' \' + tv_short_cls;\n\t\t\tvar sibling = parent.nextSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.nextSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_long_cls;\n\t\t}  else {\n\t\t\tparent.className = tv_hid + \' \' + tv_long_cls;\n\t\t\tvar sibling = parent.previousSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.previousSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_short_cls;\n\t\t}\n\t}\n</script>\n\n\n<div class="vbp-widget" id="optimedica" title="Optimedica">\n\t<div class="vbp-header">\n\n\t\t<a class="tradevibes_logo vbp-logo " href="http://venturebeatprofiles.com/company/profile/optimedica?src=widget" title="Optimedica">\n\t<img src="http://venturebeatprofiles.com/ugenimage/logo/company_73/125.png" alt="Optimedica" title="Optimedica" width="149" height="33">\n</a>\n\n\n\t\t<p class="vbp-company">\n\t\t\t<a href="http://venturebeatprofiles.com/company/profile/optimedica?src=widget"><strong>Optimedica</strong></a>\n\t\t\t<a href="http://www.optimedica.com/" target="_blank"><em>http://www.optimedica.com/</em></a>\n\t\t</p>\n\t\t<p class="vbp-utility">\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/account/profile/add_watch/optimedica?src=widget">Watch Company</a>\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/company/widget/preview/optimedica?src=widget">Get Widget</a>\n\t\t</p>\n\t</div><!-- header -->\n\t<div class="vbp-content clearfix">\n\t\t<div class="vbp-left-col vbp-col">\n\n\t\t\t<p class="vbp-description vbp-description-short tradevibes_short_description">Developer of technology for the treatment of ocular disease. The company has developed a fully integrated pattern scan laser system designed to treat retinal diseases using a single spot or a...<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">More&raquo;</a></p>\n\t\t\t<p class="vbp-description vbp-description-long vbp-hide tradevibes_hidden">Developer of technology for the treatment of ocular disease. The company has developed a fully integrated pattern scan laser system designed to treat retinal diseases using a single spot or a predetermined pattern array of up to 25 spots. The company\'s technology can be used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, retinal tears and detachments, and retinal vascular occlusive disease.<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">&laquo;Less</a></p>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Overview</h5>\n\t\t\t\t<p><strong>Location:</strong> \tSanta Clara, CA, United States\n</p>\n\t\t\t\t<p><strong>Industry:</strong> Medical Devices &amp; Equipment</p>\n\t\t\t\t<p><strong>Employees:</strong> 30</p>\n\t\t\t\t<p><strong>Tags:</strong>\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=retina">retina</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=KPCB">KPCB</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=PASCAL+Photocoagulator">PASCAL Photocoagulator</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=medical">medical</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Financials</h5>\n\t\t\t\t<p><strong>Latest Funding:</strong> Series C - $16M (03/2008)</p>\n\t\t\t\t<p><strong>Investors:</strong>\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/kleiner-perkins-caufield-byers_1?src=widget">Kleiner Perkins Caufield &amp; Byers</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/alloy-ventures_1?src=widget">Alloy Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/dag-ventures?src=widget">DAG Ventures</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\t\t</div><!-- col -->\n\t\t<div class="vbp-right-col vbp-col">\n\n\t\t\t<div class="vbp-news">\n\t\t\t\t<h5>Recent News</h5>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/optimedica?article=5381">\n\t\t\t\t\t<em>Mar 26, 2008</em>\n\t\t\t\t\t<strong>OptiMedica takes in $16M for eye-treatment laser</strong>\n\t\t\t\t</a></p>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/optimedica?article=152726">\n\t\t\t\t\t<em>Aug 20, 2009</em>\n\t\t\t\t\t<strong>OptiMedica Gets $25M</strong>\n\t\t\t\t</a></p>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/optimedica?article=2148">\n\t\t\t\t\t<em>Jan 16, 2008</em>\n\t\t\t\t\t<strong>OptiMedica Receives ISO Certification and CE Mark for the PASCAL\xae Photocoagulator; Approvals Clear Path for International Shipments</strong>\n\t\t\t\t</a></p>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/optimedica?article=2147">\n\t\t\t\t\t<em>Jan 16, 2008</em>\n\t\t\t\t\t<strong>OptiMedica names Mark Forchette CEO</strong>\n\t\t\t\t</a></p>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/optimedica?article=2146">\n\t\t\t\t\t<em>Jan 16, 2008</em>\n\t\t\t\t\t<strong>Santa Clara-Based OptiMedica Raises $13.8 Million in New Funding</strong>\n\t\t\t\t</a></p>\n\t\t\t</div>\n\n\t\t</div><!-- col -->\n\t</div><!-- content -->\n\t<p class="vbp-footer">\n\t\t<a href="http://venturebeatprofiles.com/company/profile/optimedica?src=widget">Optimedica Company Profile</a> powered by <a href="http://venturebeatprofiles.com/?src=widget">VentureBeat Profiles</a>.\n\t</p>\n</div><!-- widget -->\n'
);
		  if (typeof tradevibes_post == "function") {
			  tradevibes_post();
		  }
	  }






